Le Pape, Marc
Besnard, Céline
Acatrinei, Camelia
Guinard, Jérôme
Boutrot, Maxime
Genève, Claire
Boulain, Thierry
Barbier, François
Article History
Received: 17 October 2021
Accepted: 27 February 2022
First Online: 15 March 2022
Declarations
:
: The study protocol was approved on November 27th, 2020 by the Ethical committee of the French Society of Intensive Care (CE-SRLF-20-84). The requirement for patient’s informed consent was waived due to the retrospective design of the study.
: Not applicable.
: FB declares interests with MSD (consulting and lecture fees, and conference invitation), BioMérieux (lecture fees), and Pfizer (conference invitation), outside the scope of the submitted work. Other authors have no potential conflict of interest to declare.